vs
NovoCure Ltd（NVCR）与Ribbon Communications Inc.（RBBN）财务数据对比。点击上方公司名可切换其他公司
NovoCure Ltd的季度营收约是Ribbon Communications Inc.的1.1倍（$174.1M vs $162.6M），Ribbon Communications Inc.净利率更高（54.8% vs -40.9%，领先95.6%），NovoCure Ltd同比增速更快（12.3% vs -10.3%），过去两年NovoCure Ltd的营收复合增速更高（7.6% vs -8.1%）
NovoCure Ltd是一家全球肿瘤医疗企业，专注研发肿瘤治疗电场（TTFields）技术，推出可穿戴非侵入式癌症治疗设备，已获批用于胶质母细胞瘤、恶性胸膜间皮瘤、非小细胞肺癌等多个癌种，业务覆盖北美、欧洲及亚太地区。
睿宾通信公司（Ribbon Communications Inc.）主要为电信运营商、企业及关键基础设施领域提供软件、IP与光网络解决方案。公司于2017年由Genband与Sonus Networks合并成立，总部位于美国得克萨斯州普莱诺，是一家上市科技企业。
NVCR vs RBBN — 直观对比
营收规模更大
NVCR
是对方的1.1倍
$162.6M
营收增速更快
NVCR
高出22.6%
-10.3%
净利率更高
RBBN
高出95.6%
-40.9%
两年增速更快
NVCR
近两年复合增速
-8.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $174.1M | $162.6M |
| 净利润 | $-71.1M | $89.1M |
| 毛利率 | 77.6% | 42.9% |
| 营业利润率 | — | 37.6% |
| 净利率 | -40.9% | 54.8% |
| 营收同比 | 12.3% | -10.3% |
| 净利润同比 | -107.3% | — |
| 每股收益（稀释后） | — | $0.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NVCRRBBN
| Q1 26 | $174.1M | $162.6M | ||
| Q4 25 | $174.3M | $227.3M | ||
| Q3 25 | $167.2M | $215.4M | ||
| Q2 25 | $158.8M | $220.6M | ||
| Q1 25 | $155.0M | $181.3M | ||
| Q4 24 | $161.3M | $251.4M | ||
| Q3 24 | $155.1M | $210.2M | ||
| Q2 24 | $150.4M | $192.6M |
净利润NVCRRBBN
| Q1 26 | $-71.1M | $89.1M | ||
| Q4 25 | $-24.5M | — | ||
| Q3 25 | $-37.3M | $-12.1M | ||
| Q2 25 | $-40.1M | $-11.1M | ||
| Q1 25 | $-34.3M | $-26.2M | ||
| Q4 24 | $-65.9M | — | ||
| Q3 24 | $-30.6M | $-13.4M | ||
| Q2 24 | $-33.4M | $-16.8M |
毛利率NVCRRBBN
| Q1 26 | 77.6% | 42.9% | ||
| Q4 25 | 75.8% | 53.3% | ||
| Q3 25 | 73.2% | 50.1% | ||
| Q2 25 | 73.9% | 49.6% | ||
| Q1 25 | 75.1% | 45.4% | ||
| Q4 24 | 79.2% | 55.7% | ||
| Q3 24 | 77.2% | 52.1% | ||
| Q2 24 | 77.0% | 50.8% |
营业利润率NVCRRBBN
| Q1 26 | — | 37.6% | ||
| Q4 25 | -23.2% | 4.1% | ||
| Q3 25 | -21.5% | 1.3% | ||
| Q2 25 | -24.9% | 1.9% | ||
| Q1 25 | -24.4% | -10.8% | ||
| Q4 24 | -39.3% | 13.2% | ||
| Q3 24 | -20.7% | -0.4% | ||
| Q2 24 | -22.3% | -1.0% |
净利率NVCRRBBN
| Q1 26 | -40.9% | 54.8% | ||
| Q4 25 | -14.1% | — | ||
| Q3 25 | -22.3% | -5.6% | ||
| Q2 25 | -25.3% | -5.0% | ||
| Q1 25 | -22.1% | -14.5% | ||
| Q4 24 | -40.9% | — | ||
| Q3 24 | -19.7% | -6.4% | ||
| Q2 24 | -22.2% | -8.7% |
每股收益（稀释后）NVCRRBBN
| Q1 26 | — | $0.50 | ||
| Q4 25 | $-0.22 | $0.50 | ||
| Q3 25 | $-0.33 | $-0.07 | ||
| Q2 25 | $-0.36 | $-0.06 | ||
| Q1 25 | $-0.31 | $-0.15 | ||
| Q4 24 | $-0.61 | $0.05 | ||
| Q3 24 | $-0.28 | $-0.08 | ||
| Q2 24 | $-0.31 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $432.0M | $67.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $330.7M | $419.1M |
| 总资产 | $787.9M | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NVCRRBBN
| Q1 26 | $432.0M | $67.6M | ||
| Q4 25 | $93.5M | $96.4M | ||
| Q3 25 | $342.1M | $74.8M | ||
| Q2 25 | $149.6M | $60.5M | ||
| Q1 25 | $127.3M | $71.2M | ||
| Q4 24 | $163.8M | $87.8M | ||
| Q3 24 | $185.4M | $37.2M | ||
| Q2 24 | $164.8M | $64.6M |
总债务NVCRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | $342.1M | ||
| Q3 25 | — | $344.3M | ||
| Q2 25 | — | $346.5M | ||
| Q1 25 | — | $347.4M | ||
| Q4 24 | — | $348.3M | ||
| Q3 24 | — | $349.1M | ||
| Q2 24 | — | $350.0M |
股东权益NVCRRBBN
| Q1 26 | $330.7M | $419.1M | ||
| Q4 25 | $340.5M | $449.0M | ||
| Q3 25 | $341.3M | $360.1M | ||
| Q2 25 | $349.4M | $370.4M | ||
| Q1 25 | $362.0M | $381.8M | ||
| Q4 24 | $360.2M | $404.6M | ||
| Q3 24 | $360.8M | $395.5M | ||
| Q2 24 | $361.8M | $405.0M |
总资产NVCRRBBN
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $1.2B | ||
| Q3 25 | $1.4B | $1.1B | ||
| Q2 25 | $1.2B | $1.1B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B |
负债/权益比NVCRRBBN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.96× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | 0.86× | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NVCR
暂无分部数据
RBBN
| Service | $94.5M | 58% |
| Product | $68.1M | 42% |
